Self-Study 2025 Release I: Germline Genetic Testing in Patients with Cancer
This session will provide an overview of the prevalence of germline cancer susceptibility mutations in those who are diagnosed with cancer. Practical tips for how to recognize patients who should receive germline genetic testing will be described. The materials provided will address appropriate germline genetic test selection and discussion of risks/benefits to patients and their family members.
Germline Genetic Testing in Patients with Cancer
UAN#: 0465-0000-25-070-H99-P
Author: Amber B. Cipriani, PharmD, BCOP
Learning Objectives
- Discuss the prevalence and penetrance of germline cancer susceptibility variants in patients with cancer
- Recommend germline genetic testing in a person with cancer based on family history, cancer type, and somatic genetic testing results
- Explain the risks and benefits of germline genetic testing for cancer susceptibility
Get it here
Knowledge Course for Pharmacists
Technology requirements: HOPA Learn requires a modern web browser (Internet Explorer 7+, Mozilla Firefox, Apple Safari, Google Chrome) and the ability to listen to audio with the content.
HOPA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. In order to claim BCOP credit, you must pass the BCOP Post-Test with a 75% or higher.
All CE hours will be transmitted to the CPE Monitor and BPS within 1-2 weeks of course completion.